Da farko wanda Ralph Steinman da Zanvil Cohn suka nuna a cikin 1973, sel dendritic (DCs) suna da babban aiki na tsoma baki tare da halayen da ba za a iya kamuwa da su ba da kuma haɓaka amsawar rigakafi mai sassauƙa. Daga wannan lokacin gaba, ana kallon DCs a matsayin mafi tsananin sel masu nuna antigen (APCs), akai-akai ana kiranta da “Adjuvant Nature,” wanda aka ƙera don ƙaddamar da halayen gaskiya da juriya. Dangane da tsarewa da sarrafa antigens don gabatarwa ga ƙwayoyin T, DCs suna da iyakacin iyaka kuma suna bayyana ƙayyadaddun ƙididdiga na ƙididdigewa ko ƙididdige ƙima waɗanda ke ƙayyade amintaccen farawa ko rashin kuzari1. Dama kimanin shekaru 40 bayan haka, lokacin da aka ba Ralph Steinman lambar yabo ta Nobel don magani ko Physiology a cikin 2011 don bayyana waɗannan mahimman ƙwayoyin rigakafi na halitta, an fahimci mahimmancin DCs.
wannan immunotherapy treatment helps the body battle cancer cells with its own defense mechanism. Dendritic cell therapy is often used when regular therapies have not been effective. As of late, this treatment was proposed in India and multiple patients were relieved under the supervision of the renowned Oncologist with empowering results. Be that as it may, there are common drugs that have been developed over decades for most forms of tumo. Usage of these drugs is administered and combined with unsusceptible care, since it is realized that tumor cells weakened by chemotherapy or radiation are considerably easier to decimate with invulnerable cells than with flawless tumor cells.
Nau'in cutar daji da aka yi amfani da shi tare da dendritic cell wanda ke tushen maganin immunotherapy
- Ciwon fata
- Ciwon daji
- Ciwon daji na nono
- pancreatic ciwon daji
- Ciwon kankara
- ovarian ciwon daji
- Yin sujadar kansa
Mataki na hudu na maganin cutar kansa
Dendritic cell based immunotherapy treatment has proved to be quite a success specially with no hope stage IV cancer treatment. Patients specially on stage IV cancer can try and go for dendritic cell based immunotherapy in cancer treatment.
Asibitoci don kula da rigakafin ƙwayar dendritic a Indiya
- LDG India Ltd, Gurugram
- APAC Biotech, Noida
- Binciken kwayar halitta ta Dendritic, New Delhi
Kudin kuɗin dendritic cell wanda ke tushen maganin rigakafi a cikin Indiya
Kudin sel na dendritic wanda ke tushen maganin rigakafi na iya bambanta daga $ 8000 USD - $ 15,000 USD ya danganta da matakin cutar kansa da kula da likita da asibiti.
